• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Exclusive – EU regulator to decide on Pfizer booster at the start of October – source

September 23, 2021 by David Barret Leave a Comment

September 23, 2021

By Emilio Parodi and Francesco Guarascio

BRUSSELS (Reuters) – The European Medicines Agency (EMA) expects to decide in early October on the possible use of a booster dose of the Pfizer-BioNTech COVID-19 vaccine, a source with direct knowledge of the matter told Reuters.

It will be the EU drugs regulator’s first decision on boosters, the source said, after the U.S. Food and Drug Administration on Wednesday authorized a third dose of Pfizer for those 65 and older, all people at high risk of severe disease, and others who are regularly exposed to the virus.

“EMA’s decision on the third dose of Pfizer is expected for the beginning of October,” the source said, declining to be named because of the sensitivity of the matter.

Pfizer declined to comment, while BioNTech was not immediately available for comment.

The EU regulator said on Sept. 6 it had begun its evaluation of data submitted by Pfizer and BioNTech for a booster dose to be given six months after the second dose in people 16 years of age and older.

Moderna is also expected to submit data to the EMA this month on its booster dose, an EU document said.

In an opinion issued in early September and republished by the EMA, the European Centre for Disease Prevention and Control (ECDC) said there was no urgent need to administer booster doses to fully vaccinated individuals in the general population.

But it also noted that additional doses should already be considered for people with severely weakened immune systems as part of their primary vaccination.

Many EU states have already decided to administer a booster dose despite facing higher legal risks without a formal decision to do so by the EMA.

The EU has signed three deals with Pfizer and BioNTech for a total of 2.4 billion doses.

The latest contract covers the supply of at least 900 million shots, a large part of which is likely to be needed only if boosters are considered necessary, or if new virus variants emerge against which existing vaccination is not effective.

Over 70% of the EU’s adult population has already been fully vaccinated, and the bloc has secured an ample supply of vaccines from several manufacturers.

The ECDC has said crucial data on the need and safety of boosters are still missing, in part because it is not yet fully clear how long vaccines protect against the virus.

(Reporting by Emilio Parodi and Francesco Guarascio @fraguarascio; Additional reporting by Ludwig Burger; Editing by Josephine Mason and Jan Harvey)

Source Link Exclusive – EU regulator to decide on Pfizer booster at the start of October – source

David Barret
David Barret

Related posts:

  1. IFRC urges urgent global humanitarian support for Afghanistan
  2. Global reinsurance rates to keep rising next year – Moody’s
  3. Pro-Putin party heads for Russian election win after Navalny clampdown
  4. Italy reports 26 coronavirus deaths on Sunday, 3,838 new cases

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • The Invisible World Around Us: How Can We Capture And Clean The Air We Breathe?
  • 85-Million-Year-Old Dinosaur Eggs Dated Using “Atomic Clock For Fossils” For The First Time
  • Why Shouldn’t You Kiss Babies? New Study Shows Even Healthy Newborns Can Become Severely Ill With RSV
  • Earth Has A New Quasi-Moon – And It Has Probably Been Around For Decades
  • Want To Kill Your Prey? Do It Feather-Legged Lace Weaver Spider Style And Vomit All Over Them
  • IFLScience The Big Questions: Are We In The Anthropocene?
  • The Wildfire Paradox Affecting 440 Million People Has As Worrying A Solution As You’d Expect
  • AI May Infringe On Your Rights And Insult Your Dignity (Unless We Do Something Soon)
  • How Do You Study Cryptic Species? We’re Finally Lifting The Lid On The World’s Least Understood Mammals
  • Once-In-A-Decade Close Encounter With Hazardous Asteroid 2025 FA22 Approaches
  • With 229 Pairs, This Beautiful Animal Has The Highest Number Of Chromosomes Of Any Animal
  • “An Unimaginable Breakthrough”: Loudest-Ever Gravitational Wave Collision Proves Stephen Hawking Correct
  • Exciting Martian Mudstone Has Features That Might Be Considered Biosignatures
  • How Long Did Dinosaurs Live? “It’s A Big Surprise To People That Work On Them”
  • NASA’s Mysterious Announcement: “Clearest Sign Of Life That We’ve Ever Found On Mars”
  • New Brain Implant Can Decode Your Internal Monologue, Raising Fears Of Mind Reading
  • “Immediate, Sustained, And Devastating” Pain: The Most Venomous Mammal Packs An Extremely Nasty Sting
  • Domestic Cats Keeping Making Hybrids. That’s A Problem, And Yes – That Includes Some Pets
  • These Strange Little Lizards Have Toxic Green Blood, And No One Knows Exactly Why
  • How Does 2-In-1 Shampoo And Conditioner Work?
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version